Lin Y.-C.LING-HUNG WEICHIA-TUNG SHUNANN-LII CHENGCHIH-HUNG HSU2020-04-282020-04-2820080030-2414https://www.scopus.com/inward/record.uri?eid=2-s2.0-56749158424&doi=10.1159%2f000178761&partnerID=40&md5=fb41b188fbd037a3eba84cc5d093a31ehttps://scholars.lib.ntu.edu.tw/handle/123456789/487335Leiomyomatosis peritonealis disseminata (LPD) is a rare disease entity characterized by multiple peritoneal tumors composed of benign but proliferative smooth muscle cells. Surgery is the mainstay treatment for LPD. We present a 50-year-old woman who had previously undergone several surgical resections including bilateral oophorectomy for recurrent LPD. Because of progressive tumors in the peritoneum and metastatic tumors in the liver and lungs, systemic chemotherapy with doxorubicin and dacarbazine was prescribed. Objective tumor response was achieved and sustained for 1 year. This case presentation suggests that systemic chemotherapy may be considered as a treatment option for LPD patients developing unresectable or metastatic disease. Copyright ? 2008 S. Karger AG.[SDGs]SDG3dacarbazine; docetaxel; doxorubicin; estrogen receptor; etoposide; gemcitabine; ifosfamide; progesterone receptor; stem cell factor receptor; adult; article; cancer chemotherapy; cancer diagnosis; cancer growth; cancer recurrence; case report; continuous infusion; cytoreductive surgery; female; histopathology; human; human tissue; hysterectomy; immunohistochemistry; leiomyomatosis; leiomyomatosis peritonealis disseminata; liver metastasis; lung metastasis; multiple cycle treatment; nuclear magnetic resonance imaging; ovariectomy; pathogenesis; priority journal; Female; Humans; Leiomyomatosis; Middle Aged; Mitosis; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Uterine Neoplasmsjournal article10.1159/000178761190392492-s2.0-56749158424